Free Trial
NASDAQ:MTVA

MetaVia (MTVA) Stock Price, News & Analysis

MetaVia logo
$0.64 0.00 (0.00%)
As of 04:00 PM Eastern

About MetaVia Stock (NASDAQ:MTVA)

Key Stats

Today's Range
$0.62
$0.66
50-Day Range
$0.60
$0.78
52-Week Range
$0.56
$4.32
Volume
43,617 shs
Average Volume
329,042 shs
Market Capitalization
$15.49 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$7.50
Consensus Rating
Buy

Company Overview

MetaVia Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
46th Percentile Overall Score

MTVA MarketRank™: 

MetaVia scored higher than 46% of companies evaluated by MarketBeat, and ranked 641st out of 936 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    MetaVia has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    MetaVia has only been the subject of 1 research reports in the past 90 days.

  • Read more about MetaVia's stock forecast and price target.
  • Earnings Growth

    Earnings for MetaVia are expected to grow in the coming year, from ($3.90) to ($1.64) per share.

  • Price to Book Value per Share Ratio

    MetaVia has a P/B Ratio of 1.60. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Short Interest

    There is no current short interest data available for MTVA.
  • Dividend Yield

    MetaVia does not currently pay a dividend.

  • Dividend Growth

    MetaVia does not have a long track record of dividend growth.

  • Short Interest

    There is no current short interest data available for MTVA.
  • News Sentiment

    MetaVia has a news sentiment score of 0.81. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.64 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 4 news articles for MetaVia this week, compared to 1 article on an average week.
  • Search Interest

    1 people have searched for MTVA on MarketBeat in the last 30 days.
  • MarketBeat Follows

    1 people have added MetaVia to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, MetaVia insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 0.80% of the stock of MetaVia is held by insiders.

  • Percentage Held by Institutions

    Only 1.37% of the stock of MetaVia is held by institutions.

  • Read more about MetaVia's insider trading history.
Receive MTVA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for MetaVia and its competitors with MarketBeat's FREE daily newsletter.

MTVA Stock News Headlines

Musk’s Project Colossus could mint millionaires
I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history. And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI.
MetaVia Extends Phase 1 Trial for Obesity Drug
See More Headlines

MTVA Stock Analysis - Frequently Asked Questions

MetaVia's stock was trading at $2.03 at the beginning of 2025. Since then, MTVA shares have decreased by 68.5% and is now trading at $0.64.

MetaVia Inc. (NASDAQ:MTVA) posted its earnings results on Thursday, August, 7th. The company reported ($0.26) earnings per share for the quarter, topping analysts' consensus estimates of ($0.32) by $0.06.

Shares of MTVA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
8/07/2025
Today
8/14/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:MTVA
CIK
1638287
Employees
8
Year Founded
N/A

Price Target and Rating

High Price Target
$12.00
Low Price Target
$3.00
Potential Upside/Downside
+1,071.9%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
2 Analysts

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$27.59 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-212.00%
Return on Assets
-107.21%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
2.08
Quick Ratio
2.08

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.40 per share
Price / Book
1.60

Miscellaneous

Outstanding Shares
24,200,000
Free Float
24,004,000
Market Cap
$15.49 million
Optionable
N/A
Beta
0.26
7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report

This page (NASDAQ:MTVA) was last updated on 8/14/2025 by MarketBeat.com Staff
From Our Partners